Nobuyuki Udagawa

Q: What Schools Are Affiliated With Nobuyuki Udagawa

Nobuyuki Udagawa is affiliated with the following schools: Hokkaido University, University of Oxford, University of Tokyo, University of Melbourne, Showa University, Hyogo College of Medicine, Osaka University, Matsumoto Dental University, Kyoto University

Nobuyuki Udagawa's AcademicInfluence.com Rankings

Nobuyuki Udagawa

Biology

#13346

World Rank

#16891

Historical Rank

Biotechnology

#246

World Rank

#248

Historical Rank

Cell Biology

#737

World Rank

#752

Historical Rank

Genetics

#1485

World Rank

#1587

Historical Rank

biology Degrees

Download Badge

Biology

Nobuyuki Udagawa's Degrees

PhD Biomedical Sciences University of Tokyo
Masters Biotechnology Kyoto University
Bachelors Biochemistry University of Tokyo

Why Is Nobuyuki Udagawa Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Nobuyuki Udagawa's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. (1998) (4178)
Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. (1999) (2258)
IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. (1999) (1734)
Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction (2000) (1254)
Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. (1990) (991)
Osteoblastic cells are involved in osteoclast formation. (1988) (945)
Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. (1993) (832)
Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. (1993) (566)
Interleukin‐6 and soluble interleukin‐6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast‐like cell formation (1996) (546)
The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. (1989) (485)
Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. (2001) (445)
Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand. (1999) (430)
Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. (1999) (425)
Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis (2012) (412)
Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. (2000) (397)
Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation. (1997) (381)
Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors (1995) (371)
Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. (1998) (357)
Modulation of osteoclast differentiation by local factors. (1995) (338)
Coupling of bone resorption and formation by RANKL reverse signalling (2018) (308)
Transforming Growth Factor β Affects Osteoclast Differentiation via Direct and Indirect Actions (2001) (283)
p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function. (2002) (274)
Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone. (1998) (265)
A novel molecular mechanism modulating osteoclast differentiation and function. (1999) (264)
Role of prostaglandins in interleukin‐1‐induced bone resorption in mice in vitro (1991) (259)
The murine glucagon-like peptide-1 receptor is essential for control of bone resorption. (2008) (258)
Bone Morphogenetic Protein 2 Stimulates Osteoclast Differentiation and Survival Supported by Receptor Activator of Nuclear Factor-κB Ligand. (2001) (229)
A possible mechanism of the specific action of bisphosphonates on osteoclasts: tiludronate preferentially affects polarized osteoclasts having ruffled borders. (1995) (226)
Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor. (1998) (219)
The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures (1996) (190)
Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion. (2006) (186)
Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption. (2003) (185)
Role of colony‐stimulating factors in osteoclast development (1991) (184)
TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption (1998) (183)
Lipopolysaccharide Promotes the Survival of Osteoclasts Via Toll-Like Receptor 4, but Cytokine Production of Osteoclasts in Response to Lipopolysaccharide Is Different from That of Macrophages 1 (2003) (180)
The small GTP-binding protein, rho p21, is involved in bone resorption by regulating cytoskeletal organization in osteoclasts. (1995) (179)
Osteoclast differentiation by RANKL and OPG signaling pathways (2020) (169)
A critical role for interleukin-6 family-mediated Stat3 activation in osteoblast differentiation and bone formation. (2006) (164)
Action of RANKL and OPG for osteoclastogenesis. (2009) (164)
Preparation and characterization of a mouse osteoclast‐like multinucleated cell population (1992) (157)
Suppression of Osteoprotegerin Expression by Prostaglandin E2 Is Crucially Involved in Lipopolysaccharide-Induced Osteoclast Formation1 (2004) (157)
Identification of cell cycle–arrested quiescent osteoclast precursors in vivo (2009) (155)
Wortmannin, a specific inhibitor of phosphatidylinositol‐3 kinase, blocks osteoclastic bone resorption (1995) (149)
Regulation of bone metabolism by Wnt signals. (2016) (142)
Noncanonical Wnt5a enhances Wnt/β-catenin signaling during osteoblastogenesis (2014) (136)
MyD88 But Not TRIF Is Essential for Osteoclastogenesis Induced by Lipopolysaccharide, Diacyl Lipopeptide, and IL-1α (2004) (133)
The molecular mechanism of osteoclastogenesis in rheumatoid arthritis (2002) (131)
The molecular basis of osteoclast differentiation and activation. (2001) (128)
Prostaglandin E2 Enhances Osteoclastic Differentiation of Precursor Cells through Protein Kinase A-dependent Phosphorylation of TAK1* (2005) (128)
IL-34 and CSF-1: similarities and differences (2013) (108)
Quercetin suppresses bone resorption by inhibiting the differentiation and activation of osteoclasts. (2004) (108)
Parathyroid hormone (PTH)-related protein is a potent stimulator of osteoclast-like multinucleated cell formation to the same extent as PTH in mouse marrow cultures. (1989) (105)
Evaluation of Pharmaceuticals With a Novel 50‐Hour Animal Model of Bone Loss (2009) (104)
Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis (2000) (102)
Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand. (2001) (101)
Insulin receptor expression in primary and cultured osteoclast-like cells. (1998) (98)
Osteoclasts express high levels of p60c‐src , preferentially on ruffled border membranes (1992) (94)
Fos plays an essential role in the upregulation of RANK expression in osteoclast precursors within the bone microenvironment (2012) (94)
New resorption assay with mouse osteoclast‐like multinucleated cells formed in vitro (1993) (93)
p38 Mitogen-activated protein kinase is crucially involved in osteoclast differentiation but not in cytokine production, phagocytosis, or dendritic cell differentiation of bone marrow macrophages. (2003) (92)
Cloning of an osteoblastic cell line involved in the formation of osteoclast‐like cells (1990) (91)
Secretion of L‐glutamate from osteoclasts through transcytosis (2006) (90)
Tks5-dependent formation of circumferential podosomes/invadopodia mediates cell–cell fusion (2012) (90)
The Role of the Plasminogen System in Bone Resorption In Vitro (1999) (90)
Intracellular Calcium and Protein Kinase C Mediate Expression of Receptor Activator of Nuclear Factor-κB Ligand and Osteoprotegerin in Osteoblasts. (2000) (88)
Cells of Bone (2002) (87)
Lineage‐committed osteoclast precursors circulate in blood and settle down into bone (2011) (87)
Prostaglandin E2 strongly inhibits human osteoclast formation. (2005) (84)
Interleukin-18 (Interferon-γ–inducing Factor) Is Produced by Osteoblasts and Acts Via Granulocyte/Macrophage Colony-stimulating Factor and Not Via Interferon-γ to Inhibit Osteoclast Formation (1997) (79)
New roles of osteoblasts involved in osteoclast differentiation. (2012) (77)
Daily administration of eldecalcitol (ED‐71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone (2012) (76)
Importance of Membrane‐ or Matrix‐Associated Forms of M‐CSF and RANKL/ODF in Osteoclastogenesis Supported by SaOS‐4/3 Cells Expressing Recombinant PTH/PTHrP Receptors (2000) (76)
Generating murine osteoclasts from bone marrow. (2003) (73)
Tiludronate inhibits protein tyrosine phosphatase activity in osteoclasts. (1997) (73)
Multiwalled carbon nanotubes specifically inhibit osteoclast differentiation and function. (2009) (73)
Muramyl Dipeptide Enhances Osteoclast Formation Induced by Lipopolysaccharide, IL-1α, and TNF-α through Nucleotide-Binding Oligomerization Domain 2-Mediated Signaling in Osteoblasts1 (2005) (69)
Stimulation of Bone Formation in Cortical Bone of Mice Treated with a Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-binding Peptide That Possesses Osteoclastogenesis Inhibitory Activity (2013) (68)
A Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitro (2017) (67)
Spleen serves as a reservoir of osteoclast precursors through vitamin D-induced IL-34 expression in osteopetrotic op/op mice (2012) (66)
Generation of osteoclasts in vitro, and assay of osteoclast activity. (2007) (64)
Astrocytic phagocytosis is a compensatory mechanism for microglial dysfunction (2020) (63)
Intermittent PTH Administration Stimulates Pre‐Osteoblastic Proliferation Without Leading to Enhanced Bone Formation in Osteoclast‐Less c‐fos−/− Mice (2009) (61)
Dendritic cell-based immunotherapy targeting Wilms' tumor 1 in patients with recurrent malignant glioma. (2015) (60)
Osteoblasts provide a suitable microenvironment for the action of receptor activator of nuclear factor-kappaB ligand. (2006) (59)
Lack of vacuolar proton ATPase association with the cytoskeleton in osteoclasts of osteosclerotic (oc/oc) mice (1997) (59)
Dental Pulp and Periodontal Ligament Cells Support Osteoclastic Differentiation (2009) (57)
Human mesenchymal stem cells inhibit osteoclastogenesis through osteoprotegerin production. (2011) (57)
Human osteoclast-like cells are formed from peripheral blood mononuclear cells in a coculture with SaOS-2 cells transfected with the parathyroid hormone (PTH)/PTH-related protein receptor gene. (1999) (54)
Regulation by calcitonin and glucocorticoids of calcitonin receptor gene expression in mouse osteoclasts. (1997) (54)
Prostaglandins promote osteoclast-like cell formation by a mechanism involving cyclic adenosine 3',5'-monophosphate in mouse bone marrow cell cultures. (1989) (53)
Carbon Nanotubes Induce Bone Calcification by Bidirectional Interaction with Osteoblasts (2012) (53)
Bone Formation Is Coupled to Resorption Via Suppression of Sclerostin Expression by Osteoclasts (2017) (53)
The mechanism of osteoclast differentiation from macrophages: possible roles of T lymphocytes in osteoclastogenesis (2003) (52)
Protein kinase N3 promotes bone resorption by osteoclasts in response to Wnt5a-Ror2 signaling (2017) (52)
Osteoclastic bone resorption induced by innate immune responses. (2010) (52)
Transgenic Mice Overexpressing Macrophage Migration Inhibitory Factor (MIF) Exhibit High‐Turnover Osteoporosis (2006) (52)
Inorganic Pyrophosphatase Activity of Purified Bovine Pulp Alkaline Phosphatase at Physiological pH (1986) (52)
Reduced osteoblastic population and defective mineralization in osteopetrotic (op/op) mice. (2005) (50)
Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in osteoblasts. (2000) (49)
Osteoprotegerin Reduces the Serum Level of Receptor Activator of NF-κB Ligand Derived from Osteoblasts1 (2007) (48)
Osteoprotegerin-deficient male mice as a model for severe alveolar bone loss: comparison with RANKL-overexpressing transgenic male mice. (2013) (47)
Hormonal Regulation of Osteoclast Function (1998) (47)
Function of OPG as a traffic regulator for RANKL is crucial for controlled osteoclastogenesis (2010) (45)
Increased bone mass in mice after single injection of anti-receptor activator of nuclear factor-kappaB ligand-neutralizing antibody: evidence for bone anabolic effect of parathyroid hormone in mice with few osteoclasts. (2011) (44)
Possible involvement of focal adhesion kinase, p125FAK, in osteoclastic bone resorption (1995) (44)
VDR in Osteoblast‐Lineage Cells Primarily Mediates Vitamin D Treatment‐Induced Increase in Bone Mass by Suppressing Bone Resorption (2017) (44)
Effects of Geranylgeranoic Acid in Bone: Induction of Osteoblast Differentiation and Inhibition of Osteoclast Formation (2002) (43)
Mechanisms involved in bone resorption (2004) (43)
2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation, and crystal structure. (2008) (42)
The specific production of the third component of complement by osteoblastic cells treated with 1α,25‐dihydroxyvitamin D3 (1991) (42)
Physiological levels of calcitonin regulate the mouse osteoclast calcitonin receptor by a protein kinase Alpha-mediated mechanism. (1996) (42)
Calcitonin receptor down-regulation relates to calcitonin resistance in mature mouse osteoclasts. (1996) (41)
Regulation of osteoclast function (2012) (41)
Coordination of microtubules and the actin cytoskeleton is important in osteoclast function, but calcitonin disrupts sealing zones without affecting microtubule networks. (2006) (41)
Alisol-B, a novel phyto-steroid, suppresses the RANKL-induced osteoclast formation and prevents bone loss in mice. (2010) (41)
Increased Bone Mass in Mice after Single Injection of Anti-receptor Activator of Nuclear Factor-κB Ligand-neutralizing Antibody (2011) (40)
Wnt16 regulates osteoclast differentiation in conjunction with Wnt5a. (2015) (39)
Prostaglandin E2 Receptors EP2 and EP4 Are Down-regulated during Differentiation of Mouse Osteoclasts from Their Precursors* (2005) (38)
Tetracyclines Convert the Osteoclastic-Differentiation Pathway of Progenitor Cells To Produce Dendritic Cell-like Cells (2012) (37)
Osteoprotegerin inhibits in vitro mouse osteoclast formation induced by joint fluid from failed total hip arthroplasty. (2001) (37)
Diphenylhydantoin Inhibits Osteoclast Differentiation and Function Through Suppression of NFATc1 Signaling (2009) (35)
Involvement of vacuolar H+ -ATPase in incorporation of risedronate into osteoclasts. (2003) (34)
Destruxins, cyclodepsipeptides, block the formation of actin rings and prominent clear zones and ruffled borders in osteoclasts. (2003) (34)
Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis (2017) (33)
Osteogenic Factor Runx2 Marks a Subset of Leptin Receptor-Positive Cells that Sit Atop the Bone Marrow Stromal Cell Hierarchy (2017) (33)
Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts. (2005) (33)
Mechanisms involved in bone resorption regulated by vitamin D (2017) (33)
Localization of parathyroid hormone-related protein in osteoclasts by in situ hybridization and immunohistochemistry. (1998) (31)
Possible involvement of protein kinases and Smad2 signaling pathways on osteoclast differentiation enhanced by activin A (2001) (29)
Roles of cathelicidins in inflammation and bone loss (2014) (29)
New 19-nor-(20S)-1alpha,25-dihydroxyvitamin D3 analogs strongly stimulate osteoclast formation both in vivo and in vitro. (2007) (29)
Rab27a and Rab27b are involved in stimulation‐dependent RANKL release from secretory lysosomes in osteoblastic cells (2011) (29)
Roles of cathelicidin‐related antimicrobial peptide in murine osteoclastogenesis (2013) (28)
Isolation and characterization of osteoclast precursors that differentiate into osteoclasts on calvarial cells within a short period of time (1998) (28)
Non-canonical Wnt signals regulate cytoskeletal remodeling in osteoclasts (2018) (28)
Peptide drugs accelerate BMP‐2‐induced calvarial bone regeneration and stimulate osteoblast differentiation through mTORC1 signaling (2016) (26)
Impaired vibration of auditory ossicles in osteopetrotic mice. (2011) (26)
Parathyroid Hormone‐Related Protein Is Required for Normal Intramembranous Bone Development (2001) (26)
Lack of bone resorption in osteosclerotic (oc/oc) mice is due to a defect in osteoclast progenitors rather than the local microenvironment provided by osteoblastic cells. (1992) (25)
Parathyroid Hormone Shifts Cell Fate of a Leptin Receptor‐Marked Stromal Population from Adipogenic to Osteoblastic Lineage (2019) (24)
Polarized osteoclasts put marks of tartrate-resistant acid phosphatase on dentin slices--a simple method for identifying polarized osteoclasts. (2011) (23)
Transcytosis of calcium from bone by osteoclast-like cells evidenced by direct visualization of calcium in cells. (2005) (23)
Osteoprotegerin-dependent M cell self-regulation balances gut infection and immunity (2020) (22)
MKK6-p38 MAPK signaling pathway enhances survival but not bone-resorbing activity of osteoclasts. (2008) (22)
Expression of vacuolar H+-ATPase in osteoclasts and its role in resorption (1994) (22)
An Ultrastructural Study of Cell-Cell Contact between Mouse Spleen Cells and Calvaria-Derived Osteoblastic Cells in a Co-Culture System for Osteoclast Formation (1997) (21)
The relationship between calcium accumulation in osteoclast mitochondrial granules and bone resorption. (2009) (21)
Hypergravity suppresses bone resorption in ovariectomized rats (2011) (20)
Cardiac hypertrophy is exacerbated in aged mice lacking the osteoprotegerin gene. (2016) (19)
T-cell leukemia translocation-associated gene (TCTA) protein is required for human osteoclastogenesis. (2009) (19)
An ultrastructural evaluation of the effects of cysteine-proteinase inhibitors on osteoclastic resorptive functions (1995) (19)
c-fos antisense DNA inhibits proliferation of osteoclast progenitors in osteoclast development but not macrophage differentiation in vitro. (1996) (19)
Angiotensin II Stimulation of Cardiac Hypertrophy and Functional Decompensation in Osteoprotegerin-Deficient Mice (2016) (18)
Regulation of osteoclast function via Rho-Pkn3-c-Src pathways. (2019) (17)
Cells of BoneOsteoclast Generation (2002) (16)
Olfactomedin-like protein OLFML1 inhibits Hippo signaling and mineralization in osteoblasts. (2018) (13)
RANKL/OPG ratio regulates odontoclastogenesis in damaged dental pulp (2021) (13)
Murine osteoclasts secrete serine protease HtrA1 capable of degrading osteoprotegerin in the bone microenvironment (2019) (13)
High-performance scaffolds on titanium surfaces: osteoblast differentiation and mineralization promoted by a globular fibrinogen layer through cell-autonomous BMP signaling. (2015) (12)
Analogs of 1alpha,25-dihydroxyvitamin D3 with high potency in induction of osteoclastogenesis and prevention of dendritic cell differentiation: synthesis and biological evaluation of 2-substituted 19-norvitamin D analogs. (2006) (12)
Roles of non-canonical Wnt signaling pathways in bone resorption (2018) (11)
Arctigenin Inhibits Osteoclast Differentiation and Function by Suppressing Both Calcineurin-Dependent and Osteoblastic Cell-Dependent NFATc1 Pathways (2014) (11)
Nurse-like cells from patients with rheumatoid arthritis support the survival of osteoclast precursors via macrophage colony-stimulating factor production. (2005) (11)
Synthesis and structure-activity relationships of 16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs having side chains of different sizes. (2008) (10)
Sclerostin expression in trabecular bone is downregulated by osteoclasts (2020) (10)
The dynamin inhibitor dynasore inhibits bone resorption by rapidly disrupting actin rings of osteoclasts (2016) (10)
Docetaxel inhibits bone resorption through suppression of osteoclast formation and function in different manners (2009) (10)
Signal transduction of lipopolysaccharide-induced osteoclast differentiation. (2007) (9)
[Osteoporosis and RANKL signal]. (2011) (9)
Mineral trioxide aggregate solution inhibits osteoclast differentiation through the maintenance of osteoprotegerin expression in osteoblasts. (2011) (9)
Histochemical assessment on the cellular interplay of vascular endothelial cells and septoclasts during endochondral ossification in mice. (2020) (9)
The Vitamin D Receptor in Osteoblast-Lineage Cells Is Essential for the Proresorptive Activity of 1α,25(OH)2D3 In Vivo (2020) (8)
Effects of calcitonin on the function of human osteoclast-like cells formed from CD14-positive monocytes. (2006) (8)
Osteoporosis, osteoporotic fractures, and carotid artery calcification detected on panoramic radiographs in Japanese men and women. (2016) (7)
Association of cortical shape of the mandible on panoramic radiographs with mandibular trabecular bone structure in Japanese adults: a cone-beam CT-image analysis (2014) (7)
Cytochalasin D reduces osteoclastic bone resorption by inhibiting development of ruffled border-clear zone complex (1993) (7)
Advanced Alveolar Bone Resorption Treated With Implants, Guided Bone Regeneration, and Synthetic Grafting: A Case Report (2010) (7)
[Cytokine-mediated bone resorption]. (2014) (6)
Minocycline to be used a potential anti-bone resorption agents due to the suppression of osteoclastic bone resorption (2013) (6)
Osteocytic Osteolysis in PTH-treated Wild-type and Rankl−/− Mice Examined by Transmission Electron Microscopy, Atomic Force Microscopy, and Isotope Microscopy (2020) (5)
[Osteoclastogenesis and bone resorption]. (2009) (5)
Chapter 9 – Osteoclast Generation (2008) (5)
[Bone remodeling and mineral homeostasis]. (2006) (5)
Effect of Small-molecule GSK3 Antagonist on Differentiation of Rat Dental Pulp Cells into Odontoblasts (2020) (5)
[Role of OPG in regulation of bone remodeling]. (2006) (5)
Effects of Heat Treatment of Hydroxyapatite on Osteoblast Differentiation (2008) (4)
[Mechanism of acid production and secretion by osteoclasts]. (1992) (4)
The W9 peptide directly stimulates osteoblast differentiation via RANKL signaling (2017) (4)
[BMP and osteoclastogenesis]. (2006) (4)
[Mechanisms of alveolar bone remodeling]. (2007) (4)
Protein kinase N 3 promotes bone resorption by osteoclasts in response to Wnt 5 a-Ror 2 signaling (2017) (4)
The molecular mechanism of osteoclastogenesis: ODF/RANKL-dependent and independent pathways (2001) (4)
Effector memory CD4+T cells in mesenteric lymph nodes mediate bone loss in food-allergic enteropathy model mice, creating IL-4 dominance (2021) (4)
Osteogenic Factor Runx2 Marks a Subset of Leptin Receptor-Positive Cells that Sit Atop the Bone Marrow Stromal Cell Hierarchy (2017) (3)
Mesenchymal cell TRPM7 expression is required for bone formation via the regulation of chondrogenesis. (2022) (3)
Histochemical assessment for osteoblastic activity coupled with dysfunctional osteoclasts in c-src deficient mice. (2017) (3)
Osteoclastogenesis and Vitamin D (2018) (3)
Ror2 signaling enhances osteoclast formation in physiological and pathological conditions (2009) (3)
Polarization of osteoclasts on dental implant materials is similar to that observed on bone (2014) (3)
Osteoclastic bone resorption directly activates osteoblast function (2012) (3)
[Bone destruction caused by osteoclasts]. (2006) (3)
Odontoblast death drives cell-rich zone-derived dental tissue regeneration. (2021) (3)
A Comparative Study on the Morphological Changes in the Pharyngeal Airway Space before and after Sagittal Split Ramus Osteotomy (2012) (3)
Characterization, pharmacokinetics, and pharmacodynamics of anti-Siglec-15 antibody and its potency for treating osteoporosis and as follow-up treatment after parathyroid hormone use. (2021) (2)
Evidence for the major contribution of remodeling-based bone formation in sclerostin-deficient mice. (2022) (2)
The Mechanism of Coupling between Bone Resorption and Formation (2006) (2)
Positive and Negative Regulators of Sclerostin Expression (2022) (2)
[Osteoclastogenesis through TLR/NOD signaling]. (2005) (2)
[Possible mechanism of the specific action of bisphosphonates on osteoclasts]. (2003) (2)
[Pharmacokinetics of bisphosphonate.] (2016) (2)
Coupling of bone resorption and formation by RANKL reverse signalling (2018) (2)
Angiotensin II Induces Aortic Rupture and Dissection in Osteoprotegerin‐Deficient Mice (2022) (2)
Blockade of the angiotensin II type 1 receptor increases bone mineral density and left ventricular contractility in a mouse model of juvenile paget disease. (2019) (2)
Osteoblasts Play Important Roles in Osteoclastogenesis through Offering the Critical Microenvironment for the Action of RANKL (2007) (2)
Osteoclasts (2020) (2)
[Role of osteoclast differentiation factor, the new member of the TNF ligand family, in osteoclast differentiation and function]. (1999) (1)
The Molecular Mechanism of Osteoclast Differentiation and Activation (2000) (1)
Roles of cathelicidins in inflammation and bone loss (2014) (1)
Regulation of interleukin 11 production by osteoblasts and the role of GP-130 mediated signals in osteoclast development (1995) (1)
In-situ localization of interleukin-11 receptor mRNA in both stromal-osteoblastic cells and osteoclasts (1995) (1)
[Possible role of receptor activator of NF-kappa B ligand(RANKL) in osteoclast differentiation and function]. (2002) (1)
The failure of bone resorption in osteosclerotic () mice is due to a defect in osteoclast progenitors but not in local microenvironment (1992) (1)
Interleukin ( IL )-6 Induc t ion o f Osteoclast Dif ferent iat (2003) (0)
[Osteoclast-mediated demineralization of biomineral]. (2014) (0)
Vertical Ridge Augmentation Using Allograft and Synthetic Hydroxyapatites After Strategic Extraction (2013) (0)
Association Between Type 2 Diabetes and Classi cation of Periodontal Disease Severity in Japanese Men and Women: A Cross-Sectional Study (2021) (0)
An interleukin-18-containing agent that inhibits Osteoclastzellen (1998) (0)
Epidemiological study of Matsumoto Dental University students and faculty using antibody tests for novel coronavirus (2020) (0)
[Regulatory mechanism of osteoclast differentiation and function]. (2004) (0)
Platypus and opossum calcitonins exhibit strong activities, even though they belong to mammals. (2017) (0)
Histochemical assessment of osteoclast-like giant cells in Rankl-/- mice. (2023) (0)
ASBMR 2014 REPORT. Meeting Report on the ASBMR. Topics for basic research (osteoclast and bone resorption) in ASBMR 2014 (2015) (0)
Association between Type 2 Diabetes and Classification of Periodontal Disease Severity in Japanese Men and Women: A Cross-Sectional Study (2021) (0)
[Mechanism of action of bisphosphonate]. (2003) (0)
[The molecular mechanism of osteoclastic bone resorption and inhibitory drugs for bone resorption]. (2005) (0)
Isolation and characterization of osteoclast precursors in vivo (2010) (0)
Osteoprotegerin-dependent M cell self-regulation balances gut infection and immunity (2020) (0)
Formation Lipopolysaccharide-Induced Osteoclast Is Crucially Involved in 2 by Prostaglandin E Suppression of Osteoprotegerin Expression (2004) (0)
CO 2 Laser Irradiation Restores Collagen and VEGF Expressions of HPdLF on LPS Contaminated Titanium Surface (2018) (0)
Effects of Irradiation by Carbon Dioxide Laser Equipped With a Water Spray Function on Bone Formation in Rat Tibiae (2023) (0)
bone tissue as systemic organ supporting a life - Correlation between periodontitis and osteoporosis : bric-garn-0021 (2014) (0)
[Possible role of RANKL in bone resorption]. (2004) (0)
[Possible roles of TNF family cytokines in bone destruction of rheumatoid arthritis]. (2002) (0)
Inhibitor of protein kinase N3 suppresses excessive bone resorption in ovariectomized mice (2022) (0)
Cell-like Cells Progenitor Cells To Produce Dendritic Osteoclastic-Differentiation Pathway of Tetracyclines Convert the (0)
Physiological pH Inorganic Pyrophosphatase Activity of Purified Bovine Pulp Alkaline Phosphatase at (2011) (0)
Osteoclast Cell Lineage (2014) (0)
[Topics for basic research(osteoclast and bone resorption)in ASBMR 2016.] (2017) (0)
Osteoclast Differentiation and Function Multifunctional Regulator in Murine Osteoclast Differentiation Factor Acts as a (1999) (0)
[Topics for basic research(osteoclast and bone resorption)in ASBMR 2015]. (2016) (0)
Identification of osteoclasts in culture. (2011) (0)
from That of Macrophages Response to Lipopolysaccharide Is Different Cytokine Production of Osteoclasts in Osteoclasts Via Toll-Like Receptor 4, but Lipopolysaccharide Promotes the Survival of (2003) (0)
A bone is moving in a lively way dynamically (2016) (0)
p57Kip2 is an essential regulator of vitamin D receptor-dependent mechanisms (2023) (0)
The molecular mechanism of inflammatory bone resorption (2000) (0)
Murine osteoclasts secrete serine protease HtrA1 capable of degrading osteoprotegerin in the bone microenvironment (2019) (0)
Osteoclast survival is enhanced by p38 MAPK signaling(Oral Session,The 16th Annual Meeting of the Society for Hard Tissue Regenerative Biology in Matsumoto Dental University) (2007) (0)
Tks5-dependent formation of circumferential podosomes mediates cell-cell fusion (2012) (0)
Vitamin D in The Regulation of Osteoclasts (2020) (0)
Response to Letter to the Editor: Re: Differences in the risk of osteoporotic femur fractures among Japanese and white women as predicted by carotid artery calcification visualized on panoramic images. (2016) (0)
gp130-mediated signals in osteoclast development: Regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures (2003) (0)
Effects of muramyl dipeptide on osteoclast formation induced by LPS, IL-1 and TNF-α in mouse culture system (2005) (0)
RANKL/OPG ratio regulates odontoclastogenesis in damaged dental pulp (2021) (0)
Non-canonical Wnt signals regulate cytoskeletal remodeling in osteoclasts (2018) (0)
Odontoblast Cell Death Drives Stem Cell-Independent Cell-Rich Zone-Derived Dental Tissue Regeneration (2020) (0)
Osteoclast formation in co-cultures of spleen and osteoblastic cells using pthrp-deficient mice (1995) (0)
Erratum to: Association of cortical shape of the mandible on panoramic radiographs with mandibular trabecular bone structure in Japanese adults: a cone-beam CT-image analysis (2013) (0)
Physiological Role of Ostoclast Differentiation Factor (2001) (0)
Association of cortical shape of the mandible on panoramic radiographs with mandibular trabecular bone structure in Japanese adults: a cone-beam CT-image analysis (2013) (0)
OVEREXPRESSION OF SOYBEAN AGGLUTININ BINDING SITES IN HYPERPLASTIC DENTAL EPITHELIUM IN OSTEOPETROTIC (OP/OP) MICE (1993) (0)
This information is current as from Osteoblasts B Ligand Derived κ Receptor Activator of NF-Osteoprotegerin Reduces the Serum Level of Penninger and Naoyuki Takahashi (2006) (0)
List of Contributors (2020) (0)
The Role o f gp130-mediated Signals in Osteoclast Development: Regulation o f Interleukin 11 Production by Osteoblasts and Distribution o f Its Receptor in Bone Marrow Cultures (2003) (0)
How Does Vitamin D Regulate Osteoclastic Bone Resorption (2019) (0)
Erratum to: Association of cortical shape of the mandible on panoramic radiographs with mandibular trabecular bone structure in Japanese adults: a cone-beam CT-image analysis (2013) (0)
[Bone and Calcium Metabolisms Associated with Dental and Oral-Maxillofacial Diseases. Destructive bone resorption by osteoclasts and oral disease]. (2015) (0)
[Topics for basic research(osteoclast and bone resorption)in ASBMR 2017.] (2018) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Nobuyuki Udagawa?

Nobuyuki Udagawa is affiliated with the following schools:

Nobuyuki Udagawa's Academic­Influence.com Rankings

Nobuyuki Udagawa's Degrees

Why Is Nobuyuki Udagawa Influential?

Nobuyuki Udagawa's Published Works

Published Works

What Schools Are Affiliated With Nobuyuki Udagawa?

Nobuyuki Udagawa's AcademicInfluence.com Rankings